Imerio Capone
Rome, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 17 publications
NSD2 and miRNAs as Key Regulators of Melanoma Response to Romidepsin and Interferon-α2b Treatment.
Journal: Cancer medicine
Published: September 18, 2024
Machine Learning Reassessment of Serum Immune Factors Shows No Unique Immune Profiles Linked to Disease Outcomes in SARS-CoV-2-infected Patients at Hospital Admittance.
Journal: European journal of immunology
Published: July 24, 2024
CD8+CD103+PD1+TIM3+ T cells in glioblastoma microenvironment correlate with prognosis.
Journal: Immunology
Published: July 27, 2023
Reversing vemurafenib-resistance in primary melanoma cells by combined romidepsin and type I IFN treatment through blocking of tumorigenic signals and induction of immunogenic effects.
Journal: International journal of cancer
Published: December 22, 2022
Type I IFN-dependent antibody response at the basis of sex dimorphism in the outcome of COVID-19.
Journal: Cytokine & growth factor reviews
Published: September 24, 2020
Type I Interferons and Cancer: An Evolving Story Demanding Novel Clinical Applications.
Journal: Cancers
Published: October 24, 2019
Clinical and Immunological Outcomes in High-Risk Resected Melanoma Patients Receiving Peptide-Based Vaccination and Interferon Alpha, With or Without Dacarbazine Preconditioning: A Phase II Study.
Journal: Frontiers in oncology
Published: October 16, 2019
Clinical and Antitumor Immune Responses in Relapsed/Refractory Follicular Lymphoma Patients after Intranodal Injections of IFNα-Dendritic Cells and Rituximab: a Phase I Clinical Trial.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: February 28, 2019
Sexual Dimorphism of Immune Responses: A New Perspective in Cancer Immunotherapy.
Journal: Frontiers in immunology
Published: October 09, 2017
Antitumor Effects of Epidrug/IFNα Combination Driven by Modulated Gene Signatures in Both Colorectal Cancer and Dendritic Cells.
Journal: Cancer immunology research
Published: February 08, 2017
IFN-α potentiates the direct and immune-mediated antitumor effects of epigenetic drugs on both metastatic and stem cells of colorectal cancer.
Journal: Oncotarget
Published: October 08, 2015
Intratumoral injection of IFN-alpha dendritic cells after dacarbazine activates anti-tumor immunity: results from a phase I trial in advanced melanoma.
Journal: Journal of translational medicine
Published: November 18, 2014
Last Updated: 09/26/2026